ClinicalTrials.govpublic full text
A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer
advanced cancer, gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, hepatocellular cancer, renal cell carcinoma, non-small cell lung cancer, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 834037
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.